$1.235
+0.047 (+3.82%)Zum Schluss
PLUR-News
PLUR-Events
Pluri and ZEO ScientifiX Announce Strategic Agreement
Pluri and ZEO ScientifiX announced a definitive strategic agreement to expand the parties U.S. manufacturing and commercialization platform serving the regenerative medicine, aesthetics, wellness, and longevity markets. The partnership agreement also provides for exclusive U.S. rights to Pluri's Cellav aesthetic product line, including future offerings. Cellav, Pluri's wholly owned aesthetics subsidiary, develops cell-derived ingredients and aesthetic products that the companies intend to introduce through ZEO's commercial platform. Under the partnership agreement, Pluri will grant ZEO defined rights to its manufacturing technology and related know-how for associated with its regenerative medicine associated assets, while retaining ownership of its underlying technology and intellectual property. In consideration, ZEO will initially issue shares of its common stock representing 50% of its issued and outstanding common stock immediately following closing. The partnership agreement also provides for warrants, corporate governance and protective rights, among other matters, as well as customary representations and warranties, covenants and indemnifications of the parties. Following closing, ZEO's financial results are expected to be consolidated into Pluri's financial statements, subject to applicable accounting requirements. Closing of the proposed transaction, which is expected to occur in the fourth quarter of 2026 is subject to satisfaction of a number of conditions, including the negotiation of various ancillary agreements, securing certain approvals and the delivery of valuations, as well as other customary closing conditions. The transaction is not subject to stockholder approval by either Pluri or ZEO.
Pluri Chairman Acquires Company Loan from EIB
Pluri announced that Alejandro Weinstein, chairman of the board and the largest shareholder of the company, has entered into an agreement to acquire the company's loan from the European Investment Bank, or EIB. Upon completion of the transaction, Weinstein will replace the EIB as lender under the existing loan arrangements and will succeed to all of the lender's rights and remedies thereunder, as in effect at the time of the assignment. The underlying loan will remain outstanding, while Pluri will thereafter have no financial or repayment obligations to the EIB. The proposed assignment was reviewed and approved by a special independent committee of the company's board of directors and by the board, with approval by a majority of the independent directors.
Nasdaq and S&P 500 Hit Record Highs
Retreat in Oil prices and Treasury yields helped support investor sentiment, sending Nasdaq Composite and the S&P 500 to record highs. Utilities was the best performing sector in the index, with traders piling into the beaten down but high-yielding space, betting that the bid in the Treasury market could be sustainable. Consumer Cyclicals - still the worst S&P sector this year - also performed well, with outsized gains of about 3% among discount chains Dollar Treeand Dollar General. Tech was mixed, with losses in semiconductor equipment offset by gains in communication equipment stocks. In software, cybersecurity names were especially impressive as Palo Alto Networks, CrowdStrike, and Fortinetall notched all-time highs.In the opening hour of the evening session, S&P e-minis and Nasdaq 100 contracts are up a decimal. In commodities, WTI Crude Oil had fallen to a one-month low around $87 per barrel on easing supply concerns, though November contract is back around $90 on Tuesday evening.Check out this evening's top movers from around Wall Street, compiled by The Fly.HIGHER AFTER EARNINGS -Neogenup 10.0%Penguin Solutionsup 5.4%ALSO HIGHER -Pluriup 6.1% after equity offeringZIM Integrated Shipping Servicesup 4.3% after positive FY26 pre-announcementDOWN AFTER EARNINGS -Constellation Brandsdown 4.6%Worthington Steeldown 3.7%ALSO LOWER -Caribou Biosciencesdown 35.3% after announcing it would discontinue development activities, explore alternativesFair Isaacdown 0.8% after announcing staff cutsSpaceXdown 1.0% after FT report that the company seeks to raise $40B to purchase Nvidia, up 0.5%) chips
Selling Stockholders Plan to Sell 2.29M Common Shares
This filing relates to the offer and sale from time to time by the selling stockholders of up to 2.29M common shares. The company is not selling any shares under this prospectus and will not receive any of the proceeds from the sale of shares by the selling stockholders.
Pluri Files $200M Mixed Securities Shelf
Pluri files $200M mixed securities shelf
Ähnliche Artikel
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.




